Clinical trial
Myocardial Infarction Size Reduction With Atorvastatin
NCT00286312 · R&D Cardiologie, Other · Completed
Key facts
| NCT number | NCT00286312 |
|---|---|
| Title | Myocardial Infarction Size Reduction With Atorvastatin |
| Official title | Prevention of Reperfusion Damage and Late Left Ventricular Remodelling With Atorvastatin Administered Before Reperfusion Therapy. The REPERATOR Study |
| Lead sponsor | R&D Cardiologie, Other |
| Collaborators | UMC Utrecht |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Reperfusion Injury |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 50 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Feb 3, 2006 |
| Last update posted | May 21, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: